Showing 871-880 of 9869 results for "".
Strength in Numbers: Assessing Your Financial Position
https://practicaldermatology.com/topics/practice-management/strength-in-numbers-assessing-your-financial-position/23863/Look at your ratios and ranges to make sure you are keeping up with industry—and economic—shifts.Skincare on Tap
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skincare-on-tap/23791/Co-Founder William Giandoni discusses Skintap’s business model.DermWireTV: Arcutis Survey on PsO Impact; Tinted Sunscreen Update; Cosmetic Interventions and Illness; Dr. Seemal Desai Elected
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-arcutis-survey-on-pso-impact-tinted-sunscreen-update-cosmetic-interventions-and-illness-dr-seema-desai-elected/20089/Arcutis Biotherapeutics' survey finds Individuals with psoriasis who use topical treatments want more effective and simpler interventions. Intertriginous disease poses particular challenges. Increased availability of tinted sunscreens could increase the use of SPF among individuals with darker skinUpdates in Vitamin D and Sunscreens: Coronavirus and More
https://practicaldermatology.com/topics/skin-cancer-photoprotection/updates-in-vitamin-d-and-sunscreens-coronavirus-and-more/23450/A review of the latest findings regarding vitamin D deficiency, its possible link to COVID-19 severity, and advances in sunscreen formulation.Insights on Care for Skin of Color, Part 2
https://practicaldermatology.com/topics/skin-of-color/insights-on-care-for-skin-of-color-part-2/18185/Hilary Baldwin, MD and James Q. Del Rosso, DO continue their discussion with host Neal Bhatia, MD about managing skin of color. They address long-term management strategies and the need for cultural awareness.Advances in Understanding the Skin’s Microbiome
https://practicaldermatology.com/series/dermatology-dispatches/advances-in-understanding-the-skins-microbiome/19772/A growing body of evidence suggests that cutaneous dysbiosis plays a role in atopic dermatitis, psoriasis, acne, and rosacea, explains Adam Friedman, MD. Efforts to encourage diversity in the skin’s microbiome with pre- and probiotics may change the way dermatologists treat these diseases in the futPhysician Spotlight: Nehal N. Mehta, MD, MSCE, FAHA
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-nehal-n-mehta-md-msce-faha/20442/Psoriasis comorbidities: Is extinguishing systemic inflammation the solution?Physician Spotlight: Desiree Ratner, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-desiree-ratner-md/20505/Winning the war on non-melanoma skin cancer.Perspective: The ABD's Push for Subspecialty Certification in Mohs Surgery Will Fracture Dermatology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/perspective-the-abds-push-for-subspecialty-certification-in-mohs-surgery-will-fracture-dermatology/20502/Will SC infringe on the rights of non-certified dermatologists to preform Mohs? Could it lead to reduced exposure to this and other surgical treatments for future dermatologists in training?Stirring the Pot: Cannabinoids and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/stirring-the-pot-cannabinoids-and-atopic-dermatitis/20565/Cannabinoids are a diverse group of compounds that may hold significant therapeutic capabilities applicable to many areas of medicine, including dermatology.